Iyo Influenza A+B Antigen Rapid Test yakaedzwa zvichienzaniswa neRT-PCR.539 nasopharyngeal swabs uye oropharyngeal swabs zvakaongororwa neInfluenza A + B Rapid Test.
Zvinhu | Concentration | Zvinhu | Concentration |
Nasal Spray | 15% v/v | Hemoglobin | 10% v/v |
Mucin | 0.5 % w/v | Mupirocin | 10 mg/mL |
Nasal Drops | 15% v/v | Muromo wekugeza | / |
Chloraseptic | 1.5 mg/mL | Levofloxacin | 40 ug/mL |
Oseltamivir | 2ug/mL | Ribavirin | 0.2ug/mL |
Fluticasone propionate | 5% v/v | Ceftriaxone | 800 ug/mL |
Tobramycin | 4ug/mL | Saline Nasal Spray | 10% v/v |
Nefuruwenza A
Nzira | RT-PCR | Total Results | ||
Furuwenza A+B Rapid Test | Results | Positive | Negative | |
Positive | 116 | 1 | 117 | |
Negative | 5 | 417 | 422 | |
Total Results | 121 | 418 | 539 |
Clinical senitivity: 95.87% (95% CI: 90.69% ~ 98.22%)
Clinical chaiyo: 99.76% (95% CI: 98.66% ~ 99.96%)
Total coincidence rate:98.89% (95% CI: 97.59% ~ 99.49%).
Nefuruwenza B:
Nzira | RT-PCR | Total Results | ||
Furuwenza A+B Rapid Test | Results | Positive | Negative | |
Positive | 97 | 1 | 98 | |
Negative | 6 | 435 | 441 | |
Total Results | 103 | 436 | 539 |
Clinical senitivity: 94.17% (95% CI: 87.87% ~ 97.30%)
Clinical chaiyo: 99.77% (95% CI: 98.71% ~ 99.96%)
Total coincidence rate:98.70% (95% CI: 97.34% ~ 99.37%).
Analytical Sensitivity/LOD
Iyo kambani Hangzhou Aichek Medical Technology CO., Ltd. Jinxing Cun, Yuhang Nharaunda, Yuhang Dunhu (Ramangwana Sci-Tech Guta), Hangzhou, Zhejiang, PR China | |
SUNGO Europe BV Olympisch Stadion 24, 1076DE Amsterdam, Netherlands |
Muganho wekuonekwa (LOD) wakaonekwa nekuongorora kwakasiyana siyana kwehutachiona hwefuruwenza A uye hutachiona hwefuruwenza B muInfluenza A+B Antigen Rapid Test.Iwo akatariswa akaonekwa semazinga eLOD akaedzwa akanyorwa pazasi.
Furuwenza A (H3N2): 5×103 TCID50/mL
Furuwenza A (H1N1): 2.5×103 TCID50/mL
Furuwenza A (H1N1 pdm09): 2.5×103 TCID50/mL
Furuwenza B (Yamagata): 3.5×103 TCID50/mL
Influenza B (Victoria): 1.0×103 TCID50/mL
Analytical Specificity (Cross Reactivity)
Kuti uone kutariswa kweiyo Influenza A + B Antigen Rapid Test, akati wandei commensal kana pathogenic microorganisms anogona kunge aripo mupamusoro turakiti rekufema akaedzwa.
Akanaka uye asina kunaka emuenzaniso akapinzwa nema microbes aya akaongororwa pachikamu che106 TCID50/mL, kusanganisira SARS-CoV-2, Human coronavirus HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumotory, Parainflunza, Revrunoviruse syncytial virus, Mycoplasma pneumonia, Chlamydia pneumonia, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium tuberculosis, Haemophilus influenzae, Streptococcus pyogenes.Hapana kuyambuka-reactivity kwakaonekwa neInfluenza A+B Antigen Rapid Test.
Influenza A+B Antigen Rapid Test is a lateral flow immunoassay yakanangana nemhando yekuongorora furuwenza A uye furuwenza B maantigen mu nasopharyngeal swab uye oropharyngeal swab.
1.Professional Manufacturer, nyika-yepamusoro-soro tekinoroji "hofori" bhizinesi
2.Deliver zvinhu sechikumbiro chekuraira
3.ISO13485, CE, Gadzirira zvinyorwa zvakasiyana-siyana zvekutumira
4.Reply vatengi mibvunzo mukati maawa 24